128 related articles for article (PubMed ID: 38466026)
1. Incidence of skeletal-related events in patients with Ewing sarcoma: An observational retrospective study in Japan.
Aiba H; Kojima Y; Shimoi T; Sudo K; Yazaki S; Imai T; Yoshida A; Iwata S; Kobayashi E; Kawai A; Arakawa A; Ogawa C; Kimura H; Yonemori K
Cancer Med; 2024 Mar; 13(5):e7060. PubMed ID: 38466026
[TBL] [Abstract][Full Text] [Related]
2. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G
Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
[TBL] [Abstract][Full Text] [Related]
4. Spine-specific skeletal related events and mortality in non-small cell lung cancer patients: a single-institution analysis.
Adogwa O; Rubio DR; Buchowski JM; D'Souza A; Shlykov MA; Jennings JW
J Neurosurg Spine; 2022 Jan; 36(1):125-132. PubMed ID: 33254136
[TBL] [Abstract][Full Text] [Related]
5. Use of bisphosphonates in metastatic breast cancer: single institution review at the Dr. H. Bliss Murphy Cancer Centre.
Murphy L; McCarthy J; McCrate F; Laing K; Powell E; Seal M; Edwards S
Support Care Cancer; 2013 Jun; 21(6):1557-60. PubMed ID: 23334521
[TBL] [Abstract][Full Text] [Related]
6. Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma.
Ayala-Ramirez M; Palmer JL; Hofmann MC; de la Cruz M; Moon BS; Waguespack SG; Habra MA; Jimenez C
J Clin Endocrinol Metab; 2013 Apr; 98(4):1492-7. PubMed ID: 23436918
[TBL] [Abstract][Full Text] [Related]
7. Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13.
Katakami N; Kunikane H; Takeda K; Takayama K; Sawa T; Saito H; Harada M; Yokota S; Ando K; Saito Y; Yokota I; Ohashi Y; Eguchi K
J Thorac Oncol; 2014 Feb; 9(2):231-8. PubMed ID: 24419421
[TBL] [Abstract][Full Text] [Related]
8. Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer.
Barlev A; Song X; Ivanov B; Setty V; Chung K
J Manag Care Pharm; 2010; 16(9):693-702. PubMed ID: 21067255
[TBL] [Abstract][Full Text] [Related]
9. The economic burden of skeletal-related events among elderly men with metastatic prostate cancer.
Jayasekera J; Onukwugha E; Bikov K; Mullins CD; Seal B; Hussain A
Pharmacoeconomics; 2014 Feb; 32(2):173-91. PubMed ID: 24435407
[TBL] [Abstract][Full Text] [Related]
10. Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis.
Hussain A; Aly A; Daniel Mullins C; Qian Y; Arellano J; Onukwugha E
Cancer Med; 2016 Nov; 5(11):3300-3309. PubMed ID: 27730756
[TBL] [Abstract][Full Text] [Related]
11. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark.
Jensen AØ; Jacobsen JB; Nørgaard M; Yong M; Fryzek JP; Sørensen HT
BMC Cancer; 2011 Jan; 11():29. PubMed ID: 21261987
[TBL] [Abstract][Full Text] [Related]
12. Canadian health care institution resource utilization resulting from skeletal-related events.
Habib MJ; Merali T; Mills A; Uon V
Hosp Pract (1995); 2014 Feb; 42(1):15-22. PubMed ID: 24566592
[TBL] [Abstract][Full Text] [Related]
13. Prolonged administration of bisphosphonates is well-tolerated and effective for skeletal-related events in Chinese breast cancer patients with bone metastasis.
Ding X; Fan Y; Ma F; Li Q; Wang J; Zhang P; Yuan P; Xu B
Breast; 2012 Aug; 21(4):544-9. PubMed ID: 22627092
[TBL] [Abstract][Full Text] [Related]
14. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer.
Klaassen Z; Howard LE; de Hoedt A; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
Cancer; 2017 May; 123(9):1528-1535. PubMed ID: 28026865
[TBL] [Abstract][Full Text] [Related]
16. Symptoms Related to Moderate Skeletal-Related Events as Clues for the Diagnosis of Bone Metastasis.
Kitagawa Y; Ito T; Mizuno Y; Sudo Y; Kim Y; Tsunoda R; Takai S
J Nippon Med Sch; 2019; 86(3):159-164. PubMed ID: 31292327
[TBL] [Abstract][Full Text] [Related]
17. Retrospective database analysis of the effect of zoledronic acid on skeletal-related events and mortality in women with breast cancer and bone metastasis in a managed care plan.
Henk HJ; Kaura S
J Med Econ; 2012; 15(1):175-84. PubMed ID: 22017235
[TBL] [Abstract][Full Text] [Related]
18. Opioid Use Among Metastatic Prostate Cancer Patients With Skeletal-related Events.
Yaldo A; Wen L; Ogbonnaya A; Valderrama A; Kish J; Eaddy M; Kreilick C; Tangirala K; Shields K
Clin Ther; 2016 Aug; 38(8):1880-9. PubMed ID: 27478111
[TBL] [Abstract][Full Text] [Related]
19. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma.
Xu JY; Murphy WA; Milton DR; Jimenez C; Rao SN; Habra MA; Waguespack SG; Dadu R; Gagel RF; Ying AK; Cabanillas ME; Weitzman SP; Busaidy NL; Sellin RV; Grubbs E; Sherman SI; Hu MI
J Clin Endocrinol Metab; 2016 Dec; 101(12):4871-4877. PubMed ID: 27662441
[TBL] [Abstract][Full Text] [Related]
20. Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis.
Tsuda Y; Nakagawa T; Shinoda Y; Kanatani A; Kawai T; Taguchi S; Yamada Y; Sawada R; Kume H; Homma Y; Tanaka S; Kawano H
Int J Clin Oncol; 2017 Jun; 22(3):548-553. PubMed ID: 28044212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
